Company Filing History:
Years Active: 2007-2011
Title: Anna Russell: Innovator in Metabolic Disease Treatment
Introduction
Anna Russell is a prominent inventor based in Ramona, CA (US). She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target metabolic diseases. With a total of 2 patents, her work focuses on innovative solutions for managing serious health conditions.
Latest Patents
Anna Russell's latest patents include groundbreaking inventions related to cyanoamide compounds that serve as malonyl-CoA decarboxylase inhibitors. These inventions provide methods for utilizing these compounds in pharmaceutical compositions aimed at the prophylaxis, management, and treatment of metabolic diseases. The compounds are particularly beneficial for addressing conditions influenced by the malonyl-CoA regulated glucose and fatty acid metabolism pathway. They are indicated for the treatment of cardiovascular diseases, diabetes, cancer, and obesity.
Career Highlights
Anna Russell is currently employed at Chugai Seiyaku Kabushiki Kaisha, where she continues to advance her research and development efforts. Her work has garnered attention for its potential impact on public health and the treatment of chronic diseases.
Collaborations
Anna collaborates with notable colleagues, including Mark D Kafka and Mark E Wilson, who contribute to her research initiatives and help drive innovation in her field.
Conclusion
Anna Russell is a dedicated inventor whose work in metabolic disease treatment is paving the way for new therapeutic options. Her innovative patents and collaborations highlight her commitment to improving health outcomes through scientific advancements.